Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 1
2005 1
2006 2
2007 3
2008 7
2009 6
2010 9
2011 1
2012 5
2013 5
2014 3
2015 7
2016 12
2017 6
2018 8
2019 2
2020 10
2021 11
2022 6
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Epidemiology and Risk Factors of Uterine Fibroids.
Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Pavone D, et al. Among authors: fambrini m. Best Pract Res Clin Obstet Gynaecol. 2018 Jan;46:3-11. doi: 10.1016/j.bpobgyn.2017.09.004. Epub 2017 Oct 1. Best Pract Res Clin Obstet Gynaecol. 2018. PMID: 29054502 Review.
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial.
Meattini I, Marrazzo L, Saieva C, Desideri I, Scotti V, Simontacchi G, Bonomo P, Greto D, Mangoni M, Scoccianti S, Lucidi S, Paoletti L, Fambrini M, Bernini M, Sanchez L, Orzalesi L, Nori J, Bianchi S, Pallotta S, Livi L. Meattini I, et al. Among authors: fambrini m. J Clin Oncol. 2020 Dec 10;38(35):4175-4183. doi: 10.1200/JCO.20.00650. Epub 2020 Aug 24. J Clin Oncol. 2020. PMID: 32840419 Clinical Trial.
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial.
Livi L, Meattini I, Marrazzo L, Simontacchi G, Pallotta S, Saieva C, Paiar F, Scotti V, De Luca Cardillo C, Bastiani P, Orzalesi L, Casella D, Sanchez L, Nori J, Fambrini M, Bianchi S. Livi L, et al. Among authors: fambrini m. Eur J Cancer. 2015 Mar;51(4):451-463. doi: 10.1016/j.ejca.2014.12.013. Epub 2015 Jan 17. Eur J Cancer. 2015. PMID: 25605582 Clinical Trial.
Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer.
Pardella E, Pranzini E, Nesi I, Parri M, Spatafora P, Torre E, Muccilli A, Castiglione F, Fambrini M, Sorbi F, Cirri P, Caselli A, Puhr M, Klocker H, Serni S, Raugei G, Magherini F, Taddei ML. Pardella E, et al. Among authors: fambrini m. Cells. 2022 Dec 13;11(24):4026. doi: 10.3390/cells11244026. Cells. 2022. PMID: 36552790 Free PMC article.
Epigenetics of Estrogen and Progesterone Receptors in Endometriosis.
Chen H, Malentacchi F, Fambrini M, Harrath AH, Huang H, Petraglia F. Chen H, et al. Among authors: fambrini m. Reprod Sci. 2020 Nov;27(11):1967-1974. doi: 10.1007/s43032-020-00226-2. Epub 2020 Jul 22. Reprod Sci. 2020. PMID: 32700282 Review.
From pathogenesis to clinical practice: Emerging medical treatments for endometriosis.
Clemenza S, Sorbi F, Noci I, Capezzuoli T, Turrini I, Carriero C, Buffi N, Fambrini M, Petraglia F. Clemenza S, et al. Among authors: fambrini m. Best Pract Res Clin Obstet Gynaecol. 2018 Aug;51:92-101. doi: 10.1016/j.bpobgyn.2018.01.021. Epub 2018 Feb 15. Best Pract Res Clin Obstet Gynaecol. 2018. PMID: 29559388 Review.
104 results